Healthy volunteers test new tablet version of KBP 5074
NCT ID NCT03340753
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 14 times
Summary
This study tested a new tablet form of the experimental drug KBP 5074 against the current capsule form in 20 healthy adults aged 18 to 45. Researchers measured how the drug moves through the body and checked for side effects. The results will help decide which dose to use in future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medpace CLinical Pharmacology
Cincinnati, Ohio, 45227, United States
Conditions
Explore the condition pages connected to this study.